nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Niacin—atherosclerosis	0.243	0.3	CbGbCtD
Carteolol—CYP2D6—Simvastatin—atherosclerosis	0.192	0.237	CbGbCtD
Carteolol—CYP2D6—Lovastatin—atherosclerosis	0.188	0.232	CbGbCtD
Carteolol—CYP2D6—Pravastatin—atherosclerosis	0.188	0.232	CbGbCtD
Carteolol—Eye irritation—Lovastatin—atherosclerosis	0.00682	0.0442	CcSEcCtD
Carteolol—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00574	0.0372	CcSEcCtD
Carteolol—Diabetes mellitus—Simvastatin—atherosclerosis	0.00455	0.0295	CcSEcCtD
Carteolol—Diabetes mellitus—Niacin—atherosclerosis	0.00418	0.0271	CcSEcCtD
Carteolol—Depression—Rosuvastatin—atherosclerosis	0.00384	0.0249	CcSEcCtD
Carteolol—Sinusitis—Rosuvastatin—atherosclerosis	0.00361	0.0234	CcSEcCtD
Carteolol—Diplopia—Pravastatin—atherosclerosis	0.00358	0.0232	CcSEcCtD
Carteolol—Arrhythmia—Rosuvastatin—atherosclerosis	0.00308	0.02	CcSEcCtD
Carteolol—Sinusitis—Lovastatin—atherosclerosis	0.00306	0.0198	CcSEcCtD
Carteolol—Depression—Simvastatin—atherosclerosis	0.00304	0.0197	CcSEcCtD
Carteolol—Sinusitis—Ezetimibe—atherosclerosis	0.003	0.0194	CcSEcCtD
Carteolol—Sinusitis—Simvastatin—atherosclerosis	0.00286	0.0185	CcSEcCtD
Carteolol—Depression—Pravastatin—atherosclerosis	0.00275	0.0178	CcSEcCtD
Carteolol—Sinusitis—Pravastatin—atherosclerosis	0.00259	0.0168	CcSEcCtD
Carteolol—Dysgeusia—Lovastatin—atherosclerosis	0.00249	0.0162	CcSEcCtD
Carteolol—Visual impairment—Niacin—atherosclerosis	0.00242	0.0157	CcSEcCtD
Carteolol—Vision blurred—Lovastatin—atherosclerosis	0.0024	0.0156	CcSEcCtD
Carteolol—Visual impairment—Pravastatin—atherosclerosis	0.00238	0.0155	CcSEcCtD
Carteolol—Dysgeusia—Simvastatin—atherosclerosis	0.00233	0.0151	CcSEcCtD
Carteolol—Vision blurred—Simvastatin—atherosclerosis	0.00225	0.0146	CcSEcCtD
Carteolol—Arrhythmia—Niacin—atherosclerosis	0.00225	0.0146	CcSEcCtD
Carteolol—Insomnia—Rosuvastatin—atherosclerosis	0.00222	0.0144	CcSEcCtD
Carteolol—Arrhythmia—Pravastatin—atherosclerosis	0.00221	0.0143	CcSEcCtD
Carteolol—Palpitations—Ezetimibe—atherosclerosis	0.00221	0.0143	CcSEcCtD
Carteolol—Dysgeusia—Pravastatin—atherosclerosis	0.00211	0.0137	CcSEcCtD
Carteolol—Vision blurred—Niacin—atherosclerosis	0.00206	0.0134	CcSEcCtD
Carteolol—Vision blurred—Pravastatin—atherosclerosis	0.00203	0.0132	CcSEcCtD
Carteolol—Syncope—Niacin—atherosclerosis	0.00196	0.0127	CcSEcCtD
Carteolol—Oedema—Simvastatin—atherosclerosis	0.00194	0.0126	CcSEcCtD
Carteolol—Palpitations—Niacin—atherosclerosis	0.00193	0.0125	CcSEcCtD
Carteolol—Loss of consciousness—Niacin—atherosclerosis	0.00192	0.0125	CcSEcCtD
Carteolol—Insomnia—Lovastatin—atherosclerosis	0.00188	0.0122	CcSEcCtD
Carteolol—Dyspnoea—Lovastatin—atherosclerosis	0.00185	0.012	CcSEcCtD
Carteolol—Insomnia—Ezetimibe—atherosclerosis	0.00184	0.012	CcSEcCtD
Carteolol—Dyspnoea—Ezetimibe—atherosclerosis	0.00182	0.0118	CcSEcCtD
Carteolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00181	0.0117	CcSEcCtD
Carteolol—Oedema—Niacin—atherosclerosis	0.00179	0.0116	CcSEcCtD
Carteolol—Asthenia—Rosuvastatin—atherosclerosis	0.00176	0.0114	CcSEcCtD
Carteolol—Insomnia—Simvastatin—atherosclerosis	0.00176	0.0114	CcSEcCtD
Carteolol—Oedema—Pravastatin—atherosclerosis	0.00176	0.0114	CcSEcCtD
Carteolol—Shock—Niacin—atherosclerosis	0.00176	0.0114	CcSEcCtD
Carteolol—Dyspnoea—Simvastatin—atherosclerosis	0.00173	0.0112	CcSEcCtD
Carteolol—Hypotension—Niacin—atherosclerosis	0.00167	0.0108	CcSEcCtD
Carteolol—Dizziness—Rosuvastatin—atherosclerosis	0.00162	0.0105	CcSEcCtD
Carteolol—Insomnia—Niacin—atherosclerosis	0.00161	0.0105	CcSEcCtD
Carteolol—Dyspnoea—Niacin—atherosclerosis	0.00159	0.0103	CcSEcCtD
Carteolol—Insomnia—Pravastatin—atherosclerosis	0.00159	0.0103	CcSEcCtD
Carteolol—Dyspnoea—Pravastatin—atherosclerosis	0.00157	0.0102	CcSEcCtD
Carteolol—Headache—Rosuvastatin—atherosclerosis	0.00154	0.00996	CcSEcCtD
Carteolol—Hypersensitivity—Lovastatin—atherosclerosis	0.00153	0.00993	CcSEcCtD
Carteolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.0015	0.00974	CcSEcCtD
Carteolol—Asthenia—Lovastatin—atherosclerosis	0.00149	0.00967	CcSEcCtD
Carteolol—Asthenia—Ezetimibe—atherosclerosis	0.00146	0.00948	CcSEcCtD
Carteolol—Nausea—Rosuvastatin—atherosclerosis	0.00146	0.00945	CcSEcCtD
Carteolol—Hypersensitivity—Simvastatin—atherosclerosis	0.00143	0.00929	CcSEcCtD
Carteolol—Asthenia—Simvastatin—atherosclerosis	0.0014	0.00904	CcSEcCtD
Carteolol—Dizziness—Lovastatin—atherosclerosis	0.00137	0.00891	CcSEcCtD
Carteolol—Dizziness—Ezetimibe—atherosclerosis	0.00135	0.00874	CcSEcCtD
Carteolol—Hypersensitivity—Niacin—atherosclerosis	0.00132	0.00853	CcSEcCtD
Carteolol—Headache—Lovastatin—atherosclerosis	0.0013	0.00844	CcSEcCtD
Carteolol—Hypersensitivity—Pravastatin—atherosclerosis	0.0013	0.0084	CcSEcCtD
Carteolol—Dizziness—Simvastatin—atherosclerosis	0.00129	0.00834	CcSEcCtD
Carteolol—Asthenia—Niacin—atherosclerosis	0.00128	0.0083	CcSEcCtD
Carteolol—Headache—Ezetimibe—atherosclerosis	0.00128	0.00828	CcSEcCtD
Carteolol—Asthenia—Pravastatin—atherosclerosis	0.00126	0.00818	CcSEcCtD
Carteolol—Nausea—Lovastatin—atherosclerosis	0.00123	0.00801	CcSEcCtD
Carteolol—Headache—Simvastatin—atherosclerosis	0.00122	0.0079	CcSEcCtD
Carteolol—Nausea—Ezetimibe—atherosclerosis	0.00121	0.00785	CcSEcCtD
Carteolol—Dizziness—Niacin—atherosclerosis	0.00118	0.00765	CcSEcCtD
Carteolol—Dizziness—Pravastatin—atherosclerosis	0.00116	0.00754	CcSEcCtD
Carteolol—Nausea—Simvastatin—atherosclerosis	0.00116	0.00749	CcSEcCtD
Carteolol—Headache—Niacin—atherosclerosis	0.00112	0.00725	CcSEcCtD
Carteolol—Headache—Pravastatin—atherosclerosis	0.0011	0.00714	CcSEcCtD
Carteolol—Nausea—Niacin—atherosclerosis	0.00106	0.00688	CcSEcCtD
Carteolol—Nausea—Pravastatin—atherosclerosis	0.00104	0.00677	CcSEcCtD
Carteolol—ADRB1—GPCR downstream signaling—CNR2—atherosclerosis	7.47e-05	0.00206	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	7.47e-05	0.00206	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—UTS2—atherosclerosis	7.45e-05	0.00205	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—EDN1—atherosclerosis	7.41e-05	0.00204	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CCL5—atherosclerosis	7.36e-05	0.00203	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CNR2—atherosclerosis	7.31e-05	0.00202	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	7.3e-05	0.00201	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CX3CR1—atherosclerosis	7.3e-05	0.00201	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CASR—atherosclerosis	7.3e-05	0.00201	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—EDN1—atherosclerosis	7.25e-05	0.002	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CCL5—atherosclerosis	7.2e-05	0.00198	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CX3CL1—atherosclerosis	7.16e-05	0.00197	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	7.14e-05	0.00197	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CASR—atherosclerosis	7.14e-05	0.00197	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	7e-05	0.00193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRH1—atherosclerosis	6.98e-05	0.00193	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRH1—atherosclerosis	6.83e-05	0.00188	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CNR2—atherosclerosis	6.79e-05	0.00187	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	6.65e-05	0.00184	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	6.64e-05	0.00183	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	6.51e-05	0.0018	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	6.15e-05	0.0017	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	6.02e-05	0.00166	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	5.84e-05	0.00161	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	5.81e-05	0.0016	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	5.81e-05	0.0016	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	5.71e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—F2—atherosclerosis	5.69e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	5.69e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	5.69e-05	0.00157	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	5.66e-05	0.00156	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—F2—atherosclerosis	5.56e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	5.54e-05	0.00153	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	5.48e-05	0.00151	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	5.4e-05	0.00149	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	5.36e-05	0.00148	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	5.28e-05	0.00146	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	5.28e-05	0.00146	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	5.26e-05	0.00145	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	5.16e-05	0.00142	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	5.16e-05	0.00142	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	5.15e-05	0.00142	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	5.14e-05	0.00142	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLTP—atherosclerosis	5.07e-05	0.0014	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	5.07e-05	0.0014	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	5.05e-05	0.00139	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	5.03e-05	0.00139	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	4.97e-05	0.00137	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	4.96e-05	0.00137	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	4.94e-05	0.00136	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	4.94e-05	0.00136	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	4.86e-05	0.00134	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	4.83e-05	0.00133	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	4.71e-05	0.0013	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	4.61e-05	0.00127	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	4.51e-05	0.00125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	4.5e-05	0.00124	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	4.49e-05	0.00124	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	4.42e-05	0.00122	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	4.4e-05	0.00121	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LTA4H—atherosclerosis	4.4e-05	0.00121	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG8—atherosclerosis	4.4e-05	0.00121	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	4.39e-05	0.00121	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	4.31e-05	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	4.31e-05	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	4.23e-05	0.00117	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	4.22e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	4.22e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	4.19e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	4.16e-05	0.00115	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	4.14e-05	0.00114	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	4.1e-05	0.00113	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	4.07e-05	0.00112	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	4.01e-05	0.00111	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	4.01e-05	0.00111	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	4e-05	0.0011	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	3.95e-05	0.00109	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	3.92e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	3.92e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	3.91e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	3.87e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	3.8e-05	0.00105	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	3.78e-05	0.00104	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	3.72e-05	0.00103	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	3.69e-05	0.00102	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	3.59e-05	0.00099	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	3.57e-05	0.000986	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	3.55e-05	0.00098	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	3.53e-05	0.000974	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	3.51e-05	0.000968	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	3.5e-05	0.000964	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	3.48e-05	0.000959	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	3.48e-05	0.000959	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	3.47e-05	0.000958	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	3.45e-05	0.000952	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	3.45e-05	0.000951	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	3.4e-05	0.000938	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	3.37e-05	0.00093	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	3.3e-05	0.000911	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FABP4—atherosclerosis	3.27e-05	0.000902	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LCAT—atherosclerosis	3.27e-05	0.000902	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	3.23e-05	0.000891	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	3.21e-05	0.000886	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA4—atherosclerosis	3.21e-05	0.000885	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	3.16e-05	0.000871	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.15e-05	0.00087	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	3.14e-05	0.000867	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	3.12e-05	0.00086	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	3.12e-05	0.00086	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	3.1e-05	0.000856	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	3.09e-05	0.000852	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	3.07e-05	0.000848	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	3.05e-05	0.000841	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	3.05e-05	0.000841	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	3.04e-05	0.000838	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	3.04e-05	0.000838	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	3.04e-05	0.000838	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	3.04e-05	0.000838	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	3.01e-05	0.00083	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.97e-05	0.00082	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.97e-05	0.00082	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.97e-05	0.00082	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.92e-05	0.000805	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.91e-05	0.000804	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.85e-05	0.000787	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.79e-05	0.00077	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.76e-05	0.000762	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA2—atherosclerosis	2.76e-05	0.000762	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.76e-05	0.000762	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.76e-05	0.000762	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	2.73e-05	0.000753	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.73e-05	0.000753	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	2.67e-05	0.000736	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	2.65e-05	0.000731	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPA—atherosclerosis	2.64e-05	0.000727	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.61e-05	0.00072	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.6e-05	0.000717	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.59e-05	0.000715	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.58e-05	0.000713	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—BGN—atherosclerosis	2.55e-05	0.000704	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.54e-05	0.000702	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.53e-05	0.000697	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA5—atherosclerosis	2.53e-05	0.000697	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	2.45e-05	0.000675	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.43e-05	0.000671	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	2.39e-05	0.00066	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	2.36e-05	0.000652	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	2.35e-05	0.000649	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.35e-05	0.000648	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	2.31e-05	0.000638	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	2.3e-05	0.000635	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	2.28e-05	0.00063	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	2.26e-05	0.000625	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	2.25e-05	0.00062	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	2.23e-05	0.000616	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	2.23e-05	0.000615	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	2.21e-05	0.000611	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	2.2e-05	0.000606	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	2.18e-05	0.000602	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	2.18e-05	0.000601	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	2.13e-05	0.000588	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	2.12e-05	0.000585	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.11e-05	0.000581	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LIPC—atherosclerosis	2.09e-05	0.000577	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOC3—atherosclerosis	2.08e-05	0.000574	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	2.07e-05	0.000572	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LDLR—atherosclerosis	2.07e-05	0.00057	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	2.07e-05	0.00057	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	2.06e-05	0.000567	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	2.02e-05	0.000557	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CETP—atherosclerosis	2.02e-05	0.000557	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	2.01e-05	0.000555	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.93e-05	0.000534	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.91e-05	0.000527	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.87e-05	0.000516	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.87e-05	0.000515	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.83e-05	0.000504	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.83e-05	0.000504	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.83e-05	0.000504	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.82e-05	0.000503	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.81e-05	0.0005	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.81e-05	0.000498	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.79e-05	0.000493	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.79e-05	0.000493	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.77e-05	0.000489	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.77e-05	0.000488	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.75e-05	0.000481	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.72e-05	0.000475	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.71e-05	0.000471	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.69e-05	0.000465	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.65e-05	0.000455	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.63e-05	0.000449	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.61e-05	0.000445	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.58e-05	0.000436	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.56e-05	0.000431	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.55e-05	0.000426	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.54e-05	0.000424	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.53e-05	0.000421	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.51e-05	0.000417	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.5e-05	0.000415	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.48e-05	0.000408	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.43e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.4e-05	0.000387	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.4e-05	0.000385	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.37e-05	0.000378	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.34e-05	0.000369	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOB—atherosclerosis	1.34e-05	0.000369	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.3e-05	0.000359	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPL—atherosclerosis	1.28e-05	0.000352	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.25e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.21e-05	0.000335	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD36—atherosclerosis	1.21e-05	0.000335	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.19e-05	0.000328	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.17e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.16e-05	0.000319	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.15e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.15e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.13e-05	0.000312	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARA—atherosclerosis	1.13e-05	0.000311	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.1e-05	0.000303	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AGT—atherosclerosis	1.09e-05	0.000301	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.09e-05	0.0003	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.07e-05	0.000296	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—atherosclerosis	1.07e-05	0.000295	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.07e-05	0.000295	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.07e-05	0.000294	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.06e-05	0.000293	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAV1—atherosclerosis	1.06e-05	0.000293	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—atherosclerosis	1.06e-05	0.000292	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.05e-05	0.000288	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.04e-05	0.000288	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	9.87e-06	0.000272	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	9.77e-06	0.000269	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	9.66e-06	0.000267	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	9.65e-06	0.000266	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	9.56e-06	0.000264	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	9.33e-06	0.000257	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—atherosclerosis	9.33e-06	0.000257	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—atherosclerosis	9.15e-06	0.000252	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	9.13e-06	0.000252	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	9.05e-06	0.00025	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	8.86e-06	0.000244	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—atherosclerosis	8.39e-06	0.000231	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—atherosclerosis	8.02e-06	0.000221	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	7.34e-06	0.000202	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	6.82e-06	0.000188	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	6.67e-06	0.000184	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	6.29e-06	0.000174	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	6.16e-06	0.00017	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—atherosclerosis	3.69e-06	0.000102	CbGpPWpGaD
